Unichem Laboratories Limited (UNICHEMLAB.BO)
INR 587.6
(-2.16%)
INR 587.6
(-2.16%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 7.04 Billion INR | 12.71% |
| 2022 | 6.25 Billion INR | 4.17% |
| 2021 | 6 Billion INR | 11.49% |
| 2020 | 5.38 Billion INR | 35.76% |
| 2019 | 3.96 Billion INR | 17.09% |
| 2018 | 3.38 Billion INR | 24.11% |
| 2017 | 2.72 Billion INR | -3.14% |
| 2016 | 2.81 Billion INR | 22.18% |
| 2015 | 2.3 Billion INR | 11.02% |
| 2014 | 2.07 Billion INR | 2.06% |
| 2013 | 2.03 Billion INR | 42.26% |
| 2012 | 1.43 Billion INR | -9.44% |
| 2011 | 1.57 Billion INR | 5.13% |
| 2010 | 1.5 Billion INR | 39.73% |
| 2009 | 1.07 Billion INR | 4.02% |
| 2008 | 1.03 Billion INR | 24.15% |
| 2007 | 832.76 Million INR | -1.4% |
| 2006 | 844.61 Million INR | 21.01% |
| 2005 | 697.95 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q2 | 6.37 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 7.04 Billion INR | 0.0% |
| 2023 FY | 7.04 Billion INR | 12.71% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q4 | 6.25 Billion INR | 0.0% |
| 2022 FY | 6.25 Billion INR | 4.17% |
| 2022 Q2 | 5.9 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2021 Q2 | 5.45 Billion INR | 0.0% |
| 2021 FY | 6 Billion INR | 11.49% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 6 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q2 | 4.41 Billion INR | 0.0% |
| 2020 FY | 5.38 Billion INR | 35.76% |
| 2020 Q4 | 5.38 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2019 Q4 | 3.96 Billion INR | 0.0% |
| 2019 FY | 3.96 Billion INR | 17.09% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 3.35 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 FY | 3.38 Billion INR | 24.11% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q4 | 3.38 Billion INR | 0.0% |
| 2017 Q3 | 2.5 Billion INR | 0.0% |
| 2017 FY | 2.72 Billion INR | -3.14% |
| 2017 Q4 | 2.72 Billion INR | 8.98% |
| 2016 Q4 | 2.81 Billion INR | 0.0% |
| 2016 FY | 2.81 Billion INR | 22.18% |
| 2015 FY | 2.3 Billion INR | 11.02% |
| 2014 FY | 2.07 Billion INR | 2.06% |
| 2013 FY | 2.03 Billion INR | 42.26% |
| 2012 FY | 1.43 Billion INR | -9.44% |
| 2011 FY | 1.57 Billion INR | 5.13% |
| 2010 FY | 1.5 Billion INR | 39.73% |
| 2009 FY | 1.07 Billion INR | 4.02% |
| 2008 FY | 1.03 Billion INR | 24.15% |
| 2007 FY | 832.76 Million INR | -1.4% |
| 2006 FY | 844.61 Million INR | 21.01% |
| 2005 FY | 697.95 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 57.124% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 92.815% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | -5.713% |
| Granules India Limited | 13 Billion INR | 45.817% |
| Indoco Remedies Limited | 3.53 Billion INR | -99.591% |
| Achyut Healthcare Limited | 568 Thousand INR | -1240527.113% |
| Ajanta Pharma Limited | 8.28 Billion INR | 14.931% |
| Alkem Laboratories Limited | 26.61 Billion INR | 73.52% |
| Alpa Laboratories Limited | 136.65 Million INR | -5056.683% |
| Brooks Laboratories Limited | 96.1 Million INR | -7232.128% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | -209.229% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -389.229% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -494.928% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 88.912% |
| Eris Lifesciences Limited | 1.89 Billion INR | -272.781% |
| FDC Limited | 3.88 Billion INR | -81.203% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 71.959% |
| Gufic Biosciences Limited | 2 Billion INR | -251.491% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -6638.348% |
| Ipca Laboratories Limited | 24.71 Billion INR | 71.486% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -4598.781% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -7093.216% |
| Lasa Supergenerics Limited | 190.43 Million INR | -3600.37% |
| Laurus Labs Limited | 18.45 Billion INR | 61.815% |
| Lupin Limited | 49.53 Billion INR | 85.775% |
| Mankind Pharma Limited | 15.53 Billion INR | 54.638% |
| Medicamen Biotech Limited | 593.75 Million INR | -1086.819% |
| Medico Remedies Limited | 163.37 Million INR | -4213.323% |
| Megasoft Limited | - INR | -Infinity% |
| NATCO Pharma Limited | 7 Billion INR | -0.596% |
| Piramal Pharma Limited | 21.75 Billion INR | 67.614% |
| RPG Life Sciences Limited | 1.01 Billion INR | -597.699% |
| Sigachi Industries Limited | 707.2 Million INR | -896.421% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 92.859% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | -204.796% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -3242.628% |
| Wanbury Limited | 360.23 Million INR | -1856.173% |
| Windlas Biotech Limited | 621.89 Million INR | -1033.12% |
| ZIM Laboratories Limited | 812.62 Million INR | -767.156% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 79.527% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Divi's Laboratories Limited | 31.84 Billion INR | 77.868% |
| Hester Biosciences Limited | 755.81 Million INR | -832.346% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -545.84% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -2337.929% |
| Bal Pharma Limited | 878.11 Million INR | -702.488% |
| Strides Pharma Science Limited | 11.26 Billion INR | 37.431% |
| Venus Remedies Limited | 1.21 Billion INR | -479.075% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | -9.616% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 0.631% |
| Shilpa Medicare Limited | 3.44 Billion INR | -104.297% |
| Aarti Drugs Limited | 4.85 Billion INR | -45.028% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | -65.869% |
| Suven Life Sciences Limited | 7.08 Million INR | -99360.296% |
| Ind-Swift Limited | 640.91 Million INR | -999.485% |
| Valiant Laboratories Limited | 100.15 Million INR | -6935.927% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | -40.231% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | -95.907% |
| Themis Medicare Limited | 705.74 Million INR | -898.488% |
| Hikal Limited | 3.03 Billion INR | -132.015% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 69.08% |
| Sequent Scientific Limited | 3.46 Billion INR | -103.527% |
| Novartis India Limited | 448.6 Million INR | -1470.834% |
| Wockhardt Limited | 6.4 Billion INR | -10.106% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 45.357% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -27537.612% |
| Neuland Laboratories Limited | 3.5 Billion INR | -101.094% |
| Morepen Laboratories Limited | 2.48 Billion INR | -183.464% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -17569.915% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -469.943% |